Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, DIS, DEI

Sony Electronics Launches its First Over-the-Counter Hearing Aids in the US and Makes Hearing and Improved Accessibility Options for Consumers a Reality


Easy Set-up and Discreet Use Opens the Way to Improved Hearing Options

SAN DIEGO, Oct. 12, 2022 /PRNewswire/ -- Sony Electronics today announces the availability of its first over-the-counter (OTC) hearing aids for the U.S. market. Sony is re-imagining the hearing device space with a focus on innovation, accessibility and personalization. With the unique products, developed in partnership with WS Audiology ("WSA"), a leading innovator in hearing aid technology for more than 100 years, Sony will enhance the lives of consumers by combining its unique premium technology, ultimate ease of use, and uncompromised comfort and wearability, to deliver an unprecedented hearing experience that easily bridges the gap between the wearer and their environment.

Sony Launches Over-the-Counter Hearing Aids in US Making Hearing, Improved Accessibility Options for Consumers a Reality

The first two products to debut from the partnership are the CRE-C10 and the CRE-E10 self-fitting OTC hearing aids, designed with the understanding that one size does not fit all, and that people deserve options that best fit their unique needs, situations, and lives. Utilizing the app, the CRE-C10 and CRE-E10 intuitively adapt to each user's speech and surroundings, blending the latest technology with comfort to meet each individual's hearing goals.1

"Many people have ongoing challenges related to hearing loss and because of the negative feeling around it, they often don't seek the help they may need," says Tyler Ishida, President of Consumer Business Group, Sony Electronics. "As a leader in the audio innovation space, we are thrilled at the opportunity to improve the hearing assistance landscape with cutting-edge yet quite accessible devices that will ensure new over-the-counter solutions for those living with hearing impairment and also help general consumers engage with their surroundings in a deeper, more connected way.

Created for daily use, Sony's goal with these new devices is to break down the current barriers faced by those with signs of mild to moderate hearing loss and provide a simple, app-enabled, do-it-yourself solution that can allow for a better hearing experience.While each device features an easy-to-navigate app interface with customizable options for the wearer's specific hearing needs and preferences, the two models coming to market will provide more choice when it comes to the look and capabilities of high-end hearing devices.1  

"As a company dedicated to advancing the cause of Wonderful Sound for All, we welcome the introduction of these self-fitting hearing options, with the knowledge that more than 65% of the total U.S. consumer market- that needs better hearing care has not yet achieved it," 4 says Carsten Buhl, President, WSA Americas. "We expect these over-the-counter hearing aids to help people begin the journey to better hearing health. 

Extremely Easy to Use:
Each device can be used soon after purchase by following easy set-up with the Sony | Hearing Control App.1 Users are guided through a step-by-step process, answering a few brief questions to quickly set up and start using either device in a matter of minutes. The user-friendly app allows each device to communicate with the user's smartphone, letting them quickly personalize settings including volume control, and more to ensure the wearer hears exactly what they intend, in multiple environments.

The app also allows the wearer to "self-fit" each device.1 During the in-app self-fitting process, each Sony device self-adjusts to the most appropriate of pre-defined hearing profiles, which are based on thousands of actual, real-life audiogram results. Whether the user is in a bustling room or a peaceful nature setting, both models easily adapt to deliver an authentic, connected sound experience that puts the wearer first.

"At Sony, we strive to realize an inclusive world where everyone can participate, and we see this new product line as an opportunity to increase accessibility for many," commented Mike Nejat, Vice President, Engineering with Sony Electronics, and head of Sony's U.S. Accessibility Promotion Office. "With our unique technology heritage, we can help bridge a gap between individuals and their environment."

Two Initial Device Choices:
As one of the smallest OTC hearing aids on the market, the CRE-C10 has a sleek, discreet design that delivers exceptional sound quality, yet is virtually invisible when worn and has a long battery life of up to 70 hours of continuous use.2  

The second product debuting is the CRE-E10, which has an earbud-like design combining excellent sound quality and comfort, offering the wearer both confidence and convenience. In addition, CRE-E10 has a rechargeable battery for wireless charging that delivers up to 26 hours of continuous use and is also Bluetooth compatible letting the user easily connect to streaming audio or music (iOS only). 2, 3

Regardless of which device the user selects, both models deliver outstanding noise reduction and directionality, reducing noises from the back and sides depending on the wearer's changing environment. In addition, each device adjusts sound based on the surroundings to improve the overall listening experience.

As Sony works to fill the world with emotion through the power of creativity and technology, these new hearing devices are expected to make the conversation more accessible while offering a premium over-the-counter hearing experience at a more affordable price point than current
prescription-based devices.   

The CRE-C10 self-fitting OTC hearing aid has a suggested retail price of $999.99 and will be available for sale this month at https://electronics.sony.com/more/otc-hearing-aid/all-otc-hearing-aid/p/crec10 and through a range of third-party retailers including Amazon, Best Buy, and select hearing-care professionals.

The CRE-E10 self-fitting OTC hearing aid will be available for purchase this winter at the suggested price of $1,299.99.  For more information on the CRE-E10, please visit https://electronics.sony.com/more/otc-hearing-aid/all-otc-hearing-aid/p/cree10.  

About Sony Electronics Inc. 
Sony Electronics is a subsidiary of Sony Corporation of America and an affiliate of Sony Group Corporation, one of the most comprehensive entertainment companies in the world, with a portfolio that encompasses electronics, music, motion pictures, mobile, gaming, robotics and financial services. Headquartered in San Diego, California, Sony Electronics is a leader in electronics for the consumer and professional markets. Operations include research and development, engineering, sales, marketing, distribution and customer service. Sony Electronics creates products that innovate and inspire generations, such as the award-winning Alpha Interchangeable Lens Cameras and revolutionary high-resolution audio products. Sony is also a leading manufacturer of end-to-end solutions from 4K professional broadcast and A/V equipment to industry leading 4K and 8K Ultra HD TVs. Visit http://www.sony.com/news. for more information.

1Sony | Hearing control app ? Use app on smartphone to personalize settings. Download app at Google Play and the App Store at the time of the launch. Network services, content, operating system and software subject to terms and conditions and may be changed, interrupted or discontinued at any time and may require registration.
2Actual performance varies based on settings, environmental conditions, and usage.
3.Interoperability and compatibility among Bluetooth® devices vary.
4 Quick Statistics About Hearing. (2021, March 25). www.nidcd.nih.gov. Retrieved October 11, 2022, from https://www.nidcd.nih.gov/health/statistics/quick-statistics-hearing

SOURCE Sony Electronics, Inc.


These press releases may also interest you

at 21:00
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

at 20:05
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

at 20:00
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

at 19:30
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...

at 19:25
Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company's breakthrough RESILIA tissue technology, designed to extend the valve's durability.*...

at 19:20
DaVinci Laboratories, a division of FoodScience, LLC of Williston, Vermont is recalling 72 bottles of Amyloid Complete because it may contain undeclared shellfish (Shrimp and Crab). People who have an allergy or severe sensitivity to shellfish run...



News published on and distributed by: